Genipin Chemical Properties

Melting point:

118.0 to 123.0 °C

Boiling point:

287.83°C (rough estimate)

Density 

1.1230 (rough estimate)

refractive index 

1.4720 (estimate)

storage temp. 

Inert atmosphere,Room Temperature

solubility 

DMSO: ≥25mg/mL

form 

powder

pka

12.06±0.60(Predicted)

color 

White to Almost white

optical activity

117.7° (C=0.01 g/ml, MEOH)

λmax

240nm(MeOH)(lit.)

InChI

InChI=1S/C11H14O5/c1-15-10(13)8-5-16-11(14)9-6(4-12)2-3-7(8)9/h2,5,7,9,11-12,14H,3-4H2,1H3/t7-,9-,11-/m1/s1

InChIKey

AZKVWQKMDGGDSV-BCMRRPTOSA-N

SMILES

[C@@H]1(O)OC=C(C(OC)=O)[C@@]2([H])CC=C(CO)[C@@]12[H]

CAS DataBase Reference

6902-77-8(CAS DataBase Reference)

Safety Information

Hazard Codes 

Xn

Risk Statements 

22

Safety Statements 

3/14-36/37/39

RIDADR 

UN 2811 6.1/PG 3

WGK Germany 

3

RTECS 

GY5828000

HazardClass 

6.1

PackingGroup 

III

HS Code 

29329990

Genipin Usage And Synthesis

Chemical Properties

It is a white crystalline powder that is soluble in organic solvents such as methanol, ethanol, and DMSO. It is derived from the fruit of Gardenia jasminoides Ellis.

Uses

Genipin is an active aglycone derived from geniposide, an iridoid glycoside found in the fruit of Gardenia jasminoides Ellis. It has been used in traditional Chinese medicine and is a hydrolytic product of geniposide. Genipin is also known for its inhibitory effect on uncoupling protein 2 (UCP2).

Uses

Genipin has been used:

• in chemosensitivity assay
• in the preparation of recombinant human (rh)-odontogenic ameloblast-associated protein (ODAM) -impregnated collagen gel and in vitro mineralization assay
• in genipin gel preparation

Definition

ChEBI: Genipin is an iridoid monoterpenoid. It has a role as an uncoupling protein inhibitor, a hepatotoxic agent, an apoptosis inhibitor, an antioxidant, an anti-inflammatory agent and a cross-linking reagent.

General Description

Genipin is a natural cross linking agent, which is extracted from gardenia fruit. It prevents lipid peroxidation and production of nitric oxide. Genipin protects the hippocampal neurons from the toxicity of Alzheimer′s amyloid β protein. It has anti-inflammatory and anti-angiogenesis effects. Genipin is involved in drug delivery system.

Biochem/physiol Actions

Genipin stimulates insulin secretion in UCP2-dependent manner (Uncoupling protein 2). Genipin is a protein, collagen, gelatin, and chitosan cross-linker.

Synthesis

Synthesis of the compound (CAS:70094-79-0) from (1S,4aS,7aS)-methyl 7-(hydroxymethyl)-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,7a-tetrahydropenta[c]pyran-4-carboxylate The general steps of the synthesis were as follows: 1. 1 g of gardenia glycoside was dissolved in 30 mL of dichloromethane/water (1:1, v/v) and 100 mg of β-glucosidase was added. The reaction mixture was stirred vigorously at 37°C for 24 hours. After completion of the reaction, it was extracted three times with dichloromethane. The organic layers were combined, dried over anhydrous sodium sulfate and concentrated under reduced pressure to give 487 mg of genipin in 84% yield as a white powder. 2. 50 mg of kyonipin (0.22 mmol) was dissolved in dichloromethane and 53 mg of di-tert-butyl dicarbonate (Boc2O, 0.24 mmol) and 0.15 mL of triethylamine (Et3N, 1.11 mmol) were added sequentially. The reaction mixture was stirred for 3 hours. After completion of the reaction, 1N hydrochloric acid was added and the organic layer was separated, washed with saturated brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: hexane solution of 10% ethyl acetate) to give 51 mg of compound (i) in 71% yield as a colorless oil. 3. Compound (i) (1 eq.) was dissolved in anhydrous dichloromethane and 1.1 eq. of N-Boc-amino acid, 1.1 eq. of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC-HCl) and 0.1 eq. of 4-dimethylaminopyridine (DMAP) were added sequentially. The reaction mixture was stirred at room temperature until the ingredients were completely consumed. After completion of the reaction, it was diluted with dichloromethane and washed three times with saturated saline. The organic layer was dried with anhydrous sodium sulfate, concentrated under reduced pressure and the residue was separated by gel chromatography to give compound (ii) in 99% yield. 4. Compound (ii) (1 eq.) was dissolved in a mixture of 25 eq. of trifluoroacetic acid (TFA) and dichloromethane (CH2Cl2/TFA, 10:1, v/v), and the reaction was stirred for 2 hours. After completion of the reaction, trifluoroacetic acid was removed by concentration under reduced pressure. The residue was purified by silica gel column chromatography (eluent: 5% dichloromethane solution in methanol) to give compound 1 in 87% yield.

References

[1] Patent: US2017/298049, 2017, A1. Location in patent: Paragraph 0095; 0096; 0097; 0098
[2] Molecules, 2011, vol. 16, # 5, p. 4295 - 4304
[3] Journal of Agricultural and Food Chemistry, 2001, vol. 49, # 1, p. 430 - 432
[4] Heterocycles, 1991, vol. 32, # 8, p. 1451 - 1454
[5] Natural Product Research, 2012, vol. 26, # 8, p. 765 - 769

Genipin(6902-77-8)Related Product Information

• Catalpol
• Cabazitaxel
• ASTRAGALIN
• Paclitaxel
• Icaritin
• Anhydroicaritin
• Docetaxel
• L-Epicatechin
• Nodakenin
• PINOCEMBRIN
• Geniposidic acid
• 1-β-Glucogeniposide
• Geniposide
• Genipin
• Geniposide std.
• Genipinic acid
• Genipic acid
• (1S,4AS,7AS)-7-HYDROXYMETHYL-1-((3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-1,4A,5,7A-TETRAHYDRO-CYCLOPENTA[C]PYRAN-4-CARBOXYLIC ACID METHYL ESTER